Cancer

Director of Molecular & Cellular Biology, Cancer Vaccines & Immunotherapeutics, Oncology Research & Development - Pfizer - La Jolla, CA

11 hours ago | San Diego Biotechnology | 3 articles

Director of Molecular & Cellular Biology, Cancer Vaccines & Immunotherapeutics, Oncology Research & Development. Novel target discovery and validation.From Pfizer - Thu, 17 Sep...
Read more ...

Director of Molecular & Cellular Biology, Cancer Vaccines & Immunotherapeutics, Oncology Research & Development - Pfizer - La Jolla, CA

14 hours ago | San Diego Biotechnology | 3 articles

As a member of the senior leadership team, contribute to overall strategy and operation of the CVIT department, and to that of our overall ORD efforts.From Pfizer - Thu, 17 Sep...
Read more ...

Engineered bacteria churn out cancer biomarkers

17 hours ago | ScienceDaily

Pity the glycan. A lab has created these very tools by commandeering simple, single-celled microorganisms - namely E. coli bacteria - and engineering them to explore the...
Read more ...

Hydrofoam And Oxygen Headspace Bioreactors Improve Cell‐Free Therapeutic Protein Production Yields Through Enhanced Oxygen Transport

19 hours ago | Wiley

Abstract Protein therapeutics are powerful tools in the fight against diabetes, cancers, growth disorders, and many other debilitating diseases. However, availability is...
Read more ...

Boehringer Ingelheim And Mirati Therapeutics Announce Clinical Collaboration To Study BI 1701963, A SOS1::pan-KRAS Inhibitor In Combination With MRTX849, A KRAS G12C Selective Inhibitor

1 day ago | San Diego Biotechnology

First clinical study to evaluate novel combination blocking KRAS G12C and its activator SOS1 to potentially increase the therapeutic benefit for lung and colorectal cancer...
Read more ...

Research Associate/Senior Research Associate - Cell Therapy - Sorrento Therapeutics - San Diego, CA

1 day ago | San Diego Biotechnology | 5 articles

Is a fast growing, clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly...From Sorrento...
Read more ...

STAT Plus: With Grail in its sights, Illumina pursues grand vision that could reshape the business of cancer diagnoses

1 day ago | San Diego Biotechnology

With Grail in its sights, Illumina pursues grand vision that could reshape the business of cancer diagnoses....
Read more ...

Replicating a genome starts with a twist, a pinch, and a bit of a dance

1 day ago | Phys

The most basic activity of a living thing is to turn one copy of its genome into two copies, crafting one cell into two. That replication event begins with a set of...
Read more ...

Neoantimon: A multifunctional R package for identification of tumor-specific neoantigens

1 day ago | Oxford Journals

AbstractSummaryIt is known that some mutant peptides, such as those resulting from missense mutations and frameshift insertions, can bind to the major histocompatibility...
Read more ...

Genelux to Present Data from Phase 2 Trial of Olvi-Vec in Heavily Pre-treated Platinum-Resistant/Refractory Ovarian Cancer at ESMO Virtual Congress 2020

2 days ago | San Diego Biotechnology

Treatment with olvimulogene nanivacirepvec -primed immunochemotherapy shows promising overall survival benefit in this heavily pretreated late-stage patient population- The...
Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Securely Emerging into the Quality Nebula

Our Software Solutions Quality Document Management Success Written by: Candice Snine, Business Development Manager, PSC Biotech Quality Management in any industry is all about... Read more ...

Dyne's Upsized IPO Brings In $233M for Muscle Disorders Drug R&D

Dyne Therapeutics, a company developing genetic medicines for rare muscular disorders, has raised $233 million in an IPO that topped the preclinical-stage biotech's... Read more ...

BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation

The US is doing more in the COVID-19 space than anywhere in the world due to the strength of its innovative ecosystem, says Michelle McMurry-Heath, president & CEO of life... Read more ...

Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline

When Seres Therapeutics reported positive late-stage data for its experimental microbiome treatment last month, scientists at Finch Therapeutics cheered the results from the... Read more ...

How SARS-CoV-2 Went from Single Cases to Overwhelming Continents

Early detection and intervention stanched the first known introductions of the SARS-CoV-2 virus into North America and Europe, validating the effectiveness of quick... Read more ...

Arrowhead Pharma Shares Soar on Early Liver Data for RNAi Drug

An Arrowhead Pharmaceuticals drug for a rare liver disease now has early Phase 2 results and the data so far look good. Not only did the therapy reduce levels of a mutant... Read more ...

Easy and Affordable: Full-Length 16S HiFi Sequencing with PacBio Service...

Analysis of 16S ribosomal RNA has been used for phylogenetics and identifying prokaryotes for decades. But just as scientists have had to refine the Linnaean taxonomy system... Read more ...

Chromatin regulates expression of small RNAs to help maintain transposon...

Eukaryotic genomes are partitioned into euchromatic and heterochromatic domains to regulate gene expression and other fundamental cellular processes. However, chromatin is... Read more ...

Removing reference bias and improving indel calling in ancient DNA data...

During the last decade, the analysis of ancient DNA sequence has become a powerful tool for the study of past human populations. However, the degraded nature of aDNA means that... Read more ...

Bifrost: highly parallel construction and indexing of colored and compacted...

Memory consumption of de Bruijn graphs is often prohibitive. Most de Bruijn graph-based assemblers reduce the complexity by compacting paths into single vertices, but this is... Read more ...